FDA approves first new sickle cell drug in 20 years
The FDA approved a new medicine Friday to reduce the complications associated with sickle cell disease, a rare blood disorder. The drug, Endari, is made by privately held Emmaus Medical and is the first new treatment for sickle cell disease to secure FDA approval in almost 20 years. However, the active ingredient in Endari – L-glutamine…
Utah Standard News depends on the support of readers like you.
Good Journalism requires time, expertise, passion and money. We know you appreciate the coverage here. Please help us to continue as an alternative news website by becoming a subscriber or making a donation. To learn more about our subscription options or make a donation, click here.
To Advertise on UtahStandardNews.com, please contact us at: ed@utahstandardnews.com.
Comments - No Responses to “FDA approves first new sickle cell drug in 20 years”
Sure is empty down here...